Key facts
- Verility’s last known valuation is $8.0M (Feb 2025).
- It has raised $16.1M across 1 recorded rounds; the latest was Seed Round ($4.0M) in Jul 2022.
- Notable investors include gBETA, Mountain Group Partners, Purdue Ventures.
- Verility has filed 4 Form Ds with the SEC since 2022, most recently Mar 2026 ($150K sold to 2 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Verility
Funding rounds
1 roundsAbout Verility
Developer of a veterinary medical device designed to address the critical demand for increased meat protein. The company offers animal-side sperm quality checks and ovulation detection by rapidly analyzing cell morphology using image recognition and artificial intelligence, enabling clients to confirm if an animal is ready to enter the breeding herd.
- Sector
- Information Technology
- HQ
- Greenfield, IN, United States
- Founded
- 2018
- Employees
- 4
- Website
- verilityco.com/
- Ownership
- Privately Held (backing)
Verility doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Verility shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Verility in its N-PORT filings yet. We sweep new filings monthly.